Hiroki Nakagawa

Hiroki Nakagawa

Auto-generated profile, based on publicly available information

Hiroki Nakagawa

Department of Hepato‐Biliary‐Pancreatic Medicine Cancer Institute Hospital of Japanese Foundation for Cancer Research Tokyo Japan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2021 in Clinical Endoscopy
Verified
Journal Article
Open access
PDF file
NONaoki Okano
Naoki Okano
YIYoshinori Igarashi
Yoshinori Igarashi
KIKen Ito
Ken Ito
SMSaori Mizutani
Saori Mizutani
HNHiroki Nakagawa
Hiroki Nakagawa
YKYuui Kishimoto
Yuui Kishimoto
Background/Aims: Bleeding is a complication of endoscopic snare papillectomy for ampullary tumors. This study aimed to investigate the clinical efficacy of hypertonic saline-epinephrine (HSE) local injection before endoscopic papillectomy for prevention of bleeding.Methods: We retrospectively reviewed the data of 107 consecutive patients with ampullary tumors who underwent endoscopic papillectomy. The rates of en bloc resection, pathological resection margins, and prevention of immediate or delayed bleeding in the simple snaring resection group (Group A) and the HSE injection group (Group B) were compared.Results: A total of 44 and 63 patients were enrolled in Groups A and B, respectively. The total complete resection rate was 89.7% (96/107); the clinical complete resection rates in Group A and Group B were 86.3% (38/44) and 92.1% (58/63), respectively (p=0.354). Post-papillectomy bleeding occurred in 22 patients. In Groups A and B, the immediate bleeding rates were 20.5% (9/44) and 4.8% (3/63), respectively (p=0.0255), while the delayed bleeding rates were 7% (3/44) and 11% (7/63), respectively (p=0.52). The rates of positive horizontal and vertical pathological margin in both groups were 27% and 16%, respectively.Conclusions: HSE local injection was effective in preventing immediate bleeding and was useful for safely performing endoscopic papillectomy for ampullary tumors.

30 July 2024 in Clinical Endoscopy
Verified
Journal Article
Open access
TOTakeshi Okamoto
Takeshi Okamoto
TSTakashi Sasaki
Takashi Sasaki
TTTsuyoshi Takeda
Tsuyoshi Takeda
THTatsuki Hirai
Tatsuki Hirai
TITakahiro Ishitsuka
Takahiro Ishitsuka
NSNaoki Sasahira
Naoki Sasahira
Background/Aims: The optimal length of the uncovered portion of partially covered self-expandable metal stents (PCSEMSs) used in endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) remains unclear. This study investigated the safety and efficacy of PCSEMSs with different uncovered lengths, with a focus on stent migration and time to recurrent biliary obstruction (RBO).Methods: Outcomes of patients undergoing EUS-HGS using PCSEMSs with 5-mm and 20-mm uncovered portions at our institution from January 2016 to December 2021 were compared.Results: Sixty-two patients underwent EUS-HGS using PCSEMS (5/20-mm uncovered portions: 32/30). Stent migration occurred only in the 5-mm group. There were no differences in RBO rates (28.1% vs. 40.0%) or median time to RBO (6.8 vs. 7.1 months) between the two groups. Median overall survival (OS) was longer in the 20-mm group (3.1 vs. 4.9 months, p=0.037) due to the higher number of patients that resumed chemotherapy after EUS-HGS (56.7% vs. 28.1%, p=0.029). Good performance status, absence of hepatic metastases, and chemotherapy after EUS-HGS were independent predictors of longer OS.Conclusions: No migration was observed in patients treated with PCSEMS with 20-mm uncovered portions. Patients treated with PCSEMS with 20-mm uncovered portions performed at least as well as those treated with 5-mm uncovered portions in all material respects.

26 August 2025 in DEN Open
Verified
Journal Article
Open access
HNHiroki Nakagawa
Hiroki Nakagawa
TTTsuyoshi Takeda
Tsuyoshi Takeda
TOTakeshi Okamoto
Takeshi Okamoto
TMTakafumi Mie
Takafumi Mie
TFTakaaki Furukawa
Takaaki Furukawa
NSNaoki Sasahira
Naoki Sasahira
Background: Sedation for conventional endoscopic retrograde cholangiopancreatography (ERCP) has been reported to be safe even for elderly patients. However, the safety of sedation for balloon enteroscopy‐assisted ERCP (BE‐ERCP) has not been well‐studied in the elderly. Methods: We retrospectively analyzed consecutive patients with surgically altered anatomy who underwent their initial BE‐ERCP using midazolam and pethidine at our institution between January 2016 and December 2022. The primary outcome was the rate of cardiopulmonary complications, including hypotension, bradycardia, tachycardia, and hypoxemia. Secondary outcomes included the rates of procedural interruptions, delayed arousal, postprocedural falls, and delirium, dose of sedatives, and rate of ERCP‐related adverse events (AEs). Risk factors for cardiopulmonary complications and ERCP‐related AEs were also examined. Results: A total of 190 patients were included (elderly group: 63; non‐elderly group: 127). After propensity score matching, 55 patients were selected for each group. The total dose of midazolam was significantly lower in the elderly group (4 mg vs. 5 mg, p = 0.033). Rates of cardiopulmonary complication (11% vs. 11%, p > 0.999) and ERCP‐related AEs (6% vs. 9%, p = 0.716) were not significantly different between the two groups. The total dose of pethidine (> 35 mg) and total procedure time (≥ 51 min) were identified as risk factors for cardiopulmonary complications and ERCP‐related AEs, respectively. Conclusions: Cardiopulmonary complications and ERCP‐related AEs were similar in elderly and non‐elderly patients undergoing BE‐ERCP. With careful monitoring, sedation during BE‐ERCP appeared safe, even for elderly patients.